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Morphologically mature granulocytes from patients with chronic myeloid leukemia show significant impairment in their ability to internalize 
aggregated IgG, a ligand that is rapidly phagocytosed bynormal human granulocytes. With a view to understand the molecular basis of this defect, 
normal and leukemic granulocytes were examined for the steady-state levels ofmRNA for Fc?'RIIL a memb=are-associat~xl receptur that initially 
binds and traps the !gG-opsonized antigens. Northern blot analyses revealed that the level ofthe specific mRNA in CP,[L granulocytes was between 
0.08 and 0.69 times that seen in the normal granulocytes. This could be one of the contributory factors for the observed endocytic defect in the 
leukemic granulocytes. 
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I. INTRODUCTION 
Human neutrophils express two classes of FCT re- 
ceptors which mediate the binding and subsequent in- 
gestion of IgG-opsonized bacteriL, ~,vRll is a 40 -,_Do 
transmembrane protein, while FcTRlII is a 50-70 kDa 
molecule linked to the membrane via a Pi-tail [lJ. 
Recent studies have shown that Fc:yRlli, present in 
greater number (1.35xi0 s sites/cell), is required for the 
initial trapping and binding of the opsonized particles, 
while FcTRII is involved in the subsequent signal 
transduction and phagocytosis of the bound particle [2], 
Deficiency of any of these receptors on the cell surface 
could reduce the phagocytic ability of granulocytes and 
render the host prone to infection. 
Morphologically mature granulocytcs from patients 
with chronic myeloid leukemia (CML), exhibit several 
biochemical and functional defects. One of these is their 
impaired ability to internalize aggregated lgG, a ligand 
efficiently phagocytoscd by the normal human gr~,no- 
Iocytes [3]. This defect could arise du¢ to change(s) in: 
(a) the structure/amount of Fc?'R on the cell surface. (b) 
its association with the underlying cytoskclcton, and (c) 
subsequent transmembrane signalling events, 
With a view to understand the molecular basis of this 
defect, we have investigated the steady-state levels of 
FcyRlll mRNA in normal and CML granuiocytcs. 
Ahhrc, rhuit~,r: CML. chronic myeloid leukemia: PI. phosphatidyl- 
mosilol; PNH, paroxysmal nocturnal hemoglohinuria 
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2. MATERIALS AND METttODS 
2.1. Preparation of ceils 
Peripheral blood from normal voluntary donors w&~ collceled in 
acid-citrate-dextrose solution, :vhi!e that from untreated CML 
patients (with WBC counts of 100--g50x109/l) was collected in hcparJn 
(I0 IU/ml). Morphologically mature g anulocyles from each sample, 
were recovered from the pel|¢t al~ter FicolI-Hypaque sedimentation [4] 
of the respective buffy coats. Mononuclear ~ells and immature 
myeloid precursors, which ac,,t~mulHed at the interphase, were also 
collected from the ~ormal and CML samples respectively. After iysing 
the con:amlnating RBCs with 0.83% buffered ammonium chloride, 
the cells were washed twice with ice-cold PBS (136 mM sodium 
chloride. !mM potassium chloride, 3 mM disodium hydrogen ortho- 
phosphate. 70 mM potassium dihydrogco orthophosphate, pH 7.3). 
The pelleted fractions from normal and CML samples contained an 
average 99% and 90% viable granulocytes, respectively. 
2.2. Northern hlolting 
RNA was isolated according to the sing~c step method of 
Chomezynski and Sacehi [5], Twenty pg of total RNA from each 
sample were fractionated on a 1.8% agarosc gel containing 2.2 M 
formaldehyde, according to Manialis [6]. The separated RNAs w~, 
transferred to f~vbond ?~' membranes (Amersha,, .~.'mia~ly ,~ u,.'- 
~cribed in the accompanying instructions [7] using 2frxSSPE (3 M 
NaCI. 200 mM NaH.,PO4. 20 mM EDTA. pH 7.4). The FcTRIII 
transcript was detected using the pGP5 clone for FcTRill [8]. The 
human catalase transcript was detected using the 0.8 kb insert from 
a pSP64 clone following Hindlll aml gcoRI digestion. 
The Fc~'RI[I plasmid DNA was labelled with [0¢-P~IC'fP (BRIT. 
India) by nick tmnqlation using Ihc BRL nick translation kit. while 
the catala~ inser~ DNA was labelled using the Multiprime labelling 
kit purchased from Amcrsham. UK. Specific activilies of 10' 10' 
cpm/ug were oht:tined. 
The filtcrs were prchyhridized for I h at 42°C in 50"g~ formamide. 
5xSSPE, 5x Denhardt's olution, 0.5% SDS w/v, IO0pg/ml denatured. 
sonicated Salmon sperm DNA and {hen hybridized overnight at 42°C 
in the s=,me ~olution con{alning iff' Itf" cpm/mi of the dcnalured 
nrobe. The fil{cr.~ were ,, ,.,m:d {~:h~ with 2xSSPE/0.1% SDS for 15 
Inifl a! h'~'(: and o~ce ~th  ~xNsPl!d~ I% Sl'~,S for 30 rain al 65~( ". 
They were Saran-wrapped and c~ ~,~cd to Fu)i X-ray film I~lwc~n Iwo 
Lightning Plus Dupont Cronex mlensifyin g .~-reens at -70°C. 
rh:  inlen~hics of Ihc b:ll*~f ~,on {he attloradiogfaphs were measured 
Puhflshed hy Ei~c'.Ic.r Sclrn<'e Puhllshcr.~ B,V. [0~ 
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3. RESISTS 
T b e ~ ~  ~ of the mRNA for FcTR[il in 
~ 1 ~ ~  ~ulo~-~ the mononudear cegs 
from i ~  ~ and mtm~ m~'loid precursors 
The mteLa'ity :~  amoum::of RNA loaded were as- 
cm-~l  ~ the ca~ probe, since the catalasc 
~m~ is consfituth~dy ~ and it has been shown 
that the sigtw.ls on Northern blots are proportional to 
Fig. I shows the elhidium bre~mJde-a~ined RNA 
profiles on agarose gels and the autoradiographic 
profiles of the con'csponding blots probed ~zh the 
catala~ eDNA and the FcTRm done. It can be seen 
that the mRNA for FcTRIH is present in normal and 
CML gtan~ but it is absent in the mcnonudear 
cells and the immature r~-loid precur~. The in- 
tensities of ~ bands in the normal and CML granu- 
IocFte RNA lanes reveal that he expression i the latter 
cell population is very low. This difference vms quan- 
titated by measuring the ratios of the intensities of the 
FcTRIII signal to the eatable signal, for each lane and 
comparing the value thus oblaincd, for the normal and 
CML samples. Table L it is seen that the FcTRlll sig- 
nals for the CML granuloc~le samples, three in blot A. 
two in B and two in C are lo~:r than the corresponding 
normal samples on each bioL 
4. DISCUSSION 
CML is a clonal bcmatolog/cal disorder charac- 
terized by discordant maturation of the mycloid ple- 
Table I 
Ccmvpa~L~ of the s~eady.-stat¢ ~ of the FcFRlll mRNA in 
normal and CML granaloc~es 
Northern Sample FvfRllI~atalase* % Granulocytcs 
blms 
A N~G 1.0 99% 
N:G 0.~s 99% 
N~G t3.O. 99q, 
C~G 0.31 91% 
C:G 0.14 83~ 
C~G O.t4 90% 
B N,G 1,00 99% 
C~G O~ 90% 
C~G O.Og 91% 
C NaG 1.00 99% 
C~G O.69 ~0% 
C~G 0.56 89% 
*Ralio ol'tb¢ int~nshics ofthe Fc?'Rlll and Latalas~ signals from the 
co~---4xmding blols. 
N,G-N~G and C~G-C~G refec to;he diffel~llt normal and CIVIL gra- 
nolo¢~.~c samldcs. ,~,:~ii~ely. 
cursors [I0]. This results in circulation, inthe peripheral 
blood of morphologically mature but functionally im- 
mature granulocFtcs which are unable to internalize 
soluble aggregated IgG [3]. To investigate whether this 
defect was duc to an abnormal expression of the re- 
ceptor for lgG, the steady levels ofmRNA for Fc7Rill 
were measured. Our data shows that the mRNA for the 
molecule ispresent in reduced amounts (0.08--0.69 times 
that of normal) in leukemic granulocytes. The lowered 
amounts may be due to ~ decreased rate of transcription 
or due to the in,ability of the transcript. This may he 
one of the causes for the observed efective cndocylosis 
of aggrc~ted lgG. 
F~ 
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We have conf irmed the underexpression, by calculat-  
: ing  the FcTR i l l  mRNA signal relative to  the cata lase 
mRNA signal. The  expression o f  the Fc? 'R I I I  prote in  
has been shown to  begin at  the metamyelocyte  stage 
with the levels increasing as the cell matures  to the 
granulocytic stage [1 i]. Since immature myelo id pre-  
cursors f rom CML celig do  not express the RNA for  the 
protein,  its lowered expression in the morpho log ica l ly  
mature  CML granulocytes,  uggests that  these cells may 
be "frozen" in an earl ier stage o f  dif ferentiat ion with 
respect to this molecule.  Th is  lowered expression cannot  
be attr ibuted to contaminat ion  from myeloid precursors  
as the decrease is not  proport iona l  to the percentage o f  
immature cells in the granulocyte preparat ions  (Table  
I). 
In an earlier study, Rambaldi et al. [12] have reported 
that the mRNA fo- leukocyte alkaline phosphatase is 
absent in CML granulocytes. This protein is also a Pl- 
tailed protein like the Fc?'RIII. The lowered expression 
of these two Pldinked proteins in CML seems to follow 
the trend that is observed with respect to the decreased 
expression of Pl-linked proteins, leukocyte alkaline 
phosphatase, acetylcholine esterase, FcyRIII and dccay 
acceleration factor in PNH patients [13-16]. In the latter 
disorder however, the lowered expression of these pro- 
teins is believed to be associ~te£ -,,.'., a deficienc., in 
glycosyl-phosphatidylinositol ynthesis or its transfer to 
the protein [17] and not due to decreased levels of tne 
mRNA for these molecules [12,18]. It is most probable 
that in CML cells too, there is a common mechanism 
which controls the steady levels of the mRNA for these 
Pl-linked proteins. 
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